Acetaminophen and other risk factors for excessive warfarin anticoagulation

JAMA

Volumn 279, Issue 9, 1998, Pages 657-662

  Hylek, Elaine M ^a,b   Heiman, Heather ^a   Skates, Steven J ^a   Sheehan, Mary A ^a   Singer, Daniel E ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PARACETAMOL; VITAMIN K GROUP; WARFARIN;

AGE; ALCOHOL CONSUMPTION; ANTICOAGULATION; ARTICLE; BLEEDING; DIARRHEA; DIET; DOSE RESPONSE; PATIENT COMPLIANCE; PRIORITY JOURNAL; REFERENCE VALUE; RISK ASSESSMENT; RISK FACTOR; THROMBOEMBOLISM;

EID: 0032481644     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.279.9.657     Document Type: Article

References (44)

1. Hirsh J, Dalen JE, Deykin D, Poller L, Bussey H. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest. 1995;108:231s-246s.
2. Landefeld CS, Goldman L. Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy. Am J Med. 1989;87:144-152.
3. Fihn SD, McDonell M, Martin D, et al. Risk factors for complications of chronic anticoagulation: a multicenter study. Ann Intern Med. 1993;118:511-520.
4. Palareti G, Leali N, Coccheri S, et al. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study. Lancet. 1996;348:423-128.
5. van der Meer FJM, Rosendaal FR, Vandenbroucke JP, Briet E. Bleeding complications in oral anticoagulant therapy: an analysis of risk factors. Arch Intern Med. 1993;153:1557-1562.
6. Hylek EM, Singer DE. Risk factors for intracranial hemorrhage in outpatients taking warfarin. Ann Intern Med. 1994;120:897-902.
7. Cannegieter SC, Rosendaal FR, Wintzen AR, van der Meer FJM, Vandenbroucke JP, Briet E. Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med. 1995;333:11-17.
8. Schlesselman JJ. Case-Control Studies: Design, Conduct, Analysis. New York, NY: Oxford University Press; 1982:144-170.
9. Wells PS, Holbrook AM, Crowther NR, Hirsh J. Interactions of warfarin with drugs and food. Ann Intern Med. 1994;121:676-683.
10. Physicians' Desk Reference. Montvale, NJ: Medical Economics Data Production Co; 1995.
11. Porter RS, Sawyer WT, Lowenthal DT. Warfarin. In: Evans WE, ed. Applied Pharmacokinetics: Principles of Drug Monitoring. Spokane, Wash: Applied Therapeutics Inc; 1986.
12. Booth SL, Sadowski JA, Weihrauch JL, Ferland G. Vitamin K (phylloquinone) content of foods: a provisional table. J Food Consump Anal. 1993;6: 109-120.
13. Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic Research: Principles and Quantitative Methods. Belmont, Calif: Lifetime Learning; 1982:299.
14. Mehta CR, Patel NR, Gray R. Computing an exact confidence interval for the common odds ratio in several 2×2 contingency tables. J Am Stat Assoc. 1985;80:969-973.
15. Snedecor GW, Cochran WG. Statistical Methods. 7th ed. Ames: Iowa State University Press; 1980:206-208.
16. DeGroot MH. Probability and Statistics. Reading, Mass: Addison-Wesley Publishing Co; 1986:552-560.
17. Jones RH. Longitudinal Data With Serial Correlation: A State-Space Approach. London, England: Chapman & Hall; 1993:171-181.
18. Bartle WR, Blakely JA. Potentiation of warfarin anticoagulation by acetaminophen. JAMA. 1991; 265:1260.
19. Boeijinga JJ, Boerstra EE, Ris P. Interaction between paracetamol and coumarin anticoagulants. Lancet. 1982;1:506.
20. Antlitz AM, Mead JA, Tolentino MA. Potentiation of oral anticoagulant therapy by acetaminophen. Curr Ther Res. 1968;10:501-507.
21. Antlitz AM, Await LF. A double-blind study of acetaminophen used in conjunction with oral anticoagulant therapy. Curr Ther Res. 1969;11:360-361.
22. Rubin RN, Mentzer RL, Budzynski AZ. Potentiation of anticoagulant effect of warfarin by acetaminophen (Tylenol) [abstract]. Clin Res. 1984;32: 698a.
23. Majerus PW, Broze GJ, Miletich JP, Tollefsen DM. Anticoagulant, thrombolytic, and antiplatelet drugs. In: Hardman JG, Limbird LE, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 9th ed. New York, NY: McGraw-Hill; 1996: 1346-1350.
24. Pedersen FM, Hamberg O, Hess K, Ovesen L. The effect of vitamin K on warfarin-induced anticoagulation. J Intern Med. 1991;229:517-520.
25. Kempin SJ. Warfarin resistance caused by broccoli. N Engl J Med. 1983;308:1229-1230.
26. Karlson B, Leijd B, Hellstrom. On the influence of vitamin K-rich vegetables and wine on the effectiveness of warfarin treatment. Acta Med Scand. 1986;220:347-350.
27. Chow WH, Chow TC, Tse TM, Tai YT, Lee WT. Anticoagulation instability with life-threatening complication after dietary modification. Postgrad Med J. 1990;66:855-857.
28. Hennekens CH, Buring JE. Epidemiology in Medicine. Boston, Mass: Little Brown & Co; 1987: 148.
29. Laliberte R, Chakrabarti S, Brodeur J. The influence of fasting and stress on the response of rats to warfarin. J Pharmacol Exp Ther. 1976;196:194-203.
30. Laliberte R, Chakrabarti S, Brodeur J. The influence of fasting on the disposition of warfarin in rats. J Pharmacol Exp Ther. 1977;200:44-51.
31. Black JA. Diarrhoea, vitamin K, and warfarin. Lancet. 1994;344:1373.
32. Kater RMH, Roggin G, Tobon P, Zieve P, Iber FL. Increased rate of clearance of drugs from the circulation of alcoholics. Am J Med Sci. 1969;258:35-39.
33. O'Reilly RA. Lack of effect of fortified wine ingested during fasting and anticoagulant therapy. Arch Intern Med. 1981;141:458-459.
34. Ahlbom A, Norell S. Introduction to Modern Epidemiology. Chestnut Hill, Mass: Epidemiology Resources Inc; 1990:47-60.
35. Rogers AS. Unintended drug effects: identification and attribution. In: Hartzema AG, Porta MS, Tilson HH, eds. Pharmacoepidemiology: An Introduction. 2nd ed. Cincinnati, Ohio: Harvey Whitney Books Co; 1991:64-74.
36. Anticoagulants. In: Bennett DR, ed. Drug Evaluations Annual 1995. Chicago, Ill: American Medical Association; 1995:773-774.
37. Caron J, Libersa C. The coumarins (warfarin and other coumarin congeners). In: Dukes MNG, ed. Meyler's Side Effects of Drugs: An Encyclopedia, of Adverse Reactions and Interactions. 12th ed. Amsterdam, the Netherlands: Elsevier Science Publishers BV; 1992:900-903.
38. Stockley IH. Anticoagulants and paracetamol. In: Drug Interactions: A Source Book of Drug Interactions, Their Mechanisms, Clinical Importance and Management. 2nd ed. Oxford, England: Blackwell Scientific Publications; 1991:196-197.
39. Anticoagulants (systemic). In: United States Pharmocopeia Dispensing Information: Drug Information for the Health Care Professional. 17th ed. Rockville, Md: United States Pharmacopeial Convention Inc; 1997:232-238.
40. Dale J, Myhre E, Loew D. Bleeding during acetylsalicylic acid and anticoagulant therapy in patients with reduced platelet reactivity after aortic valve replacement. Am Heart J. 1980;99:746-751.
41. Schulman S, Henriksson K. Interaction of ibuprofen and warfarin on primary haemostasis. Br J Rheumatol. 1989;38:46-49.
42. Shorr RI, Ray WA, Daugherty JR, Griffin MR. Concurrent use of nonsteroidal anti-inflammatory drugs and oral anticoagulants places elderly persons at high risk for hemorrhagic peptic ulcer disease. Arch Intern Med. 1993;153:1665-1669.
43. Cole P, MacMahon B. Atttributable risk percent in case-control studies. Br J Prev Soc Med. 1971; 25:242-244.
44. Stafford RS, Singer DE. National patterns of warfarin use in atrial fibrillation. Arch Intern Med. 1996;156:2537-2541.